Newly diagnosed early-to-mild dementia due to Alzheimer's Disease research hub

A Phase 2 Theranostic Trial Evaluating the Effects of Thiethylperazine in Patients Diagnosed with an Early Stage of Alzheimer's disease

This study is looking into a new treatment for early Alzheimer's disease. It's testing if a medicine called thiethylperazine can slow down changes in the brain linked to Alzheimer's, using special brain scans and blood tests.